"Designing Growth Strategies is in our DNA"

Orphan Drugs Market Size, Share & Industry Analysis, By Therapy Area (Oncology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, Infectious Diseases, and Others), By Drug Type (Biologics and Non-Biologics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), and Regional Forecast, 2024-2032

Last Updated: November 04, 2024 | Format: PDF | Report ID: FBI100088

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Rare Diseases, By Key Countries/Regions, 2023
    2. Pipeline Analysis, By Key Players
    3. New Product Launches
    4. Key Industry Developments: Mergers, Acquisitions & Partnerships
    5. Technological Developments
    6. Impact of COVID-19 on the Global Orphan Drugs Market
  5. Global Orphan Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Therapy Area
      1. Oncology
      2. Hematology
      3. Neurology
      4. Endocrinology
      5. Cardiovascular
      6. Respiratory
      7. Immunotherapy
      8. Infectious Diseases
      9. Others
    2. Market Analysis, Insights and Forecast – By Drug Type
      1. Biologics
      2. Non-Biologics
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Orphan Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Therapy Area
      1. Oncology
      2. Hematology
      3. Neurology
      4. Endocrinology
      5. Cardiovascular
      6. Respiratory
      7. Immunotherapy
      8. Infectious Diseases
      9. Others
    2. Market Analysis, Insights and Forecast – By Drug Type
      1. Biologics
      2. Non-Biologics
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    4. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe Orphan Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Therapy Area
      1. Oncology
      2. Hematology
      3. Neurology
      4. Endocrinology
      5. Cardiovascular
      6. Respiratory
      7. Immunotherapy
      8. Infectious Diseases
      9. Others
    2. Market Analysis, Insights and Forecast – By Drug Type
      1. Biologics
      2. Non-Biologics
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Orphan Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Therapy Area
      1. Oncology
      2. Hematology
      3. Neurology
      4. Endocrinology
      5. Cardiovascular
      6. Respiratory
      7. Immunotherapy
      8. Infectious Diseases
      9. Others
    2. Market Analysis, Insights and Forecast – By Drug Type
      1. Biologics
      2. Non-Biologics
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Orphan Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Therapy Area
      1. Oncology
      2. Hematology
      3. Neurology
      4. Endocrinology
      5. Cardiovascular
      6. Respiratory
      7. Immunotherapy
      8. Infectious Diseases
      9. Others
    2. Market Analysis, Insights and Forecast – By Drug Type
      1. Biologics
      2. Non-Biologics
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  10. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. Amgen Inc. (U.S.)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Bayer AG (Germany)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. F. Hoffmann-La Roche Ltd (Switzerland)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Alexion Pharmaceuticals Inc. (U.S.)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Novo Nordisk A/S (Denmark)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Novartis AG (Switzerland)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Bristol-Myers Squibb Company (U.S.)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. AstraZeneca (U.K.)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. DAIICHI SANKYO COMPANY, LIMITED (Japan)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. GlaxoSmithKline plc (U.K.)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Orphan Drugs Market Revenue Breakdown (USD billion, %) By Region, 2023 & 2032

Figure 2: Global Orphan Drugs Market Value Share (%), By Therapy Area, 2023 & 2032

Figure 3: Global Orphan Drugs Market Value Share (%), By Drug Type, 2023 & 2032

Figure 4: Global Orphan Drugs Market Value Share (%), By Distribution Channels, 2023 & 2032

Figure 5: Global Orphan Drugs Market Value (USD billion), By Region, 2023 & 2032

Figure 6: North America Orphan Drugs Market Value (USD billion), By Therapy Area, 2023 & 2032

Figure 7: North America Orphan Drugs Market Value Share (%), By Therapy Area, 2023

Figure 8: North America Orphan Drugs Market Value (USD billion), By Drug Type, 2023 & 2032

Figure 9: North America Orphan Drugs Market Value Share (%), By Drug Type, 2023

Figure 10: North America Orphan Drugs Market Value (USD billion), By Distribution Channels, 2023 & 2032

Figure 11: North America Orphan Drugs Market Value Share (%), By Distribution Channels, 2023

Figure 12: North America Orphan Drugs Market Value (USD billion), By Country, 2023 & 2032

Figure 13: North America Orphan Drugs Market Value Share (%), By Country, 2023

Figure 14: Europe Orphan Drugs Market Value (USD billion), By Therapy Area, 2023 & 2032

Figure 15: Europe Orphan Drugs Market Value Share (%), By Therapy Area, 2023

Figure 16: Europe Orphan Drugs Market Value (USD billion), By Drug Type, 2023 & 2032

Figure 17: Europe Orphan Drugs Market Value Share (%), By Drug Type, 2023

Figure 18: Europe Orphan Drugs Market Value (USD billion), By Distribution Channels, 2023 & 2032

Figure 19: Europe Orphan Drugs Market Value Share (%), By Distribution Channels, 2023

Figure 20: Europe Orphan Drugs Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 21: Europe Orphan Drugs Market Value Share (%), By Country/ Sub-region, 2023

Figure 22: Asia Pacific Orphan Drugs Market Value (USD billion), By Therapy Area, 2023 & 2032

Figure 23: Asia Pacific Orphan Drugs Market Value Share (%), By Therapy Area, 2023

Figure 24: Asia Pacific Orphan Drugs Market Value (USD billion), By Drug Type, 2023 & 2032

Figure 25: Asia Pacific Orphan Drugs Market Value Share (%), By Drug Type, 2023

Figure 26: Asia Pacific Orphan Drugs Market Value (USD billion), By Distribution Channels, 2023 & 2032

Figure 27: Asia Pacific Orphan Drugs Market Value Share (%), By Distribution Channels, 2023

Figure 28: Asia Pacific Orphan Drugs Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 29: Asia Pacific Orphan Drugs Market Value Share (%), By Country/ Sub-region, 2023

Figure 30: Rest of the World Orphan Drugs Market Value (USD billion), By Therapy Area, 2023 & 2032

Figure 31: Rest of the World Orphan Drugs Market Value Share (%), By Therapy Area, 2023

Figure 32: Rest of the World Orphan Drugs Market Value (USD billion), By Drug Type, 2023 & 2032

Figure 33: Rest of the World Orphan Drugs Market Value Share (%), By Drug Type, 2023

Figure 34: Rest of the World Orphan Drugs Market Value (USD billion), By Distribution Channels, 2023 & 2032

Figure 35: Rest of the World Orphan Drugs Market Value Share (%), By Distribution Channels, 2023

Figure 36: Global Orphan Drugs Market Share (%), By Company, 2023

Table 1: Global Orphan Drugs Market Revenue (USD billion) Forecast, By Therapy Area, 2019–2032

Table 2: Global Orphan Drugs Market Revenue (USD billion) Forecast, By Drug Type, 2019–2032

Table 3: Global Orphan Drugs Market Revenue (USD billion) Forecast, By Distribution Channels, 2019–2032

Table 4: Global Orphan Drugs Market Revenue (USD billion) Forecast, By Region, 2019-2032

Table 5: North America Orphan Drugs Market Revenue (USD billion) Forecast, By Therapy Area, 2019-2032

Table 6: North America Orphan Drugs Market Revenue (USD billion) Forecast, By Drug Type, 2019-2032

Table 7: North America Orphan Drugs Market Revenue (USD billion) Forecast, By Distribution Channels, 2019-2032

Table 8: North America Orphan Drugs Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 9: Europe Orphan Drugs Market Revenue (USD billion) Forecast, By Therapy Area, 2019-2032

Table 10: Europe Orphan Drugs Market Revenue (USD billion) Forecast, By Drug Type, 2019-2032

Table 11: Europe Orphan Drugs Market Revenue (USD billion) Forecast, By Distribution Channels, 2019-2032

Table 12: Europe Orphan Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 13: Asia Pacific Orphan Drugs Market Revenue (USD billion) Forecast, By Therapy Area, 2019-2032

Table 14: Asia Pacific Orphan Drugs Market Revenue (USD billion) Forecast, By Drug Type, 2019-2032

Table 15: Asia Pacific Orphan Drugs Market Revenue (USD billion) Forecast, By Distribution Channels, 2019-2032

Table 16: Asia Pacific Orphan Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 17: Rest of the World Orphan Drugs Market Revenue (USD billion) Forecast, By Therapy Area, 2019-2032

Table 18: Rest of the World Orphan Drugs Market Revenue (USD billion) Forecast, By Drug Type, 2019-2032

Table 19: Rest of the World Orphan Drugs Market Revenue (USD billion) Forecast, By Distribution Channels, 2019-2032

Orphan Drugs Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 135
  • Buy Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X